Related Experiment Videos
Naltrexone suppresses the rejection of cardiac tissue transplantation
Abstract:
The present study demonstrates the following: 1. Transplantation of cardiac tissue induces an inflammatory response that ultimately leads to the rejection of the tissue by the host within 9 days; 2. Treatment with the opiate antagonist, naltrexone, significantly increased the survival of the transplanted cardiac tissue to 13 days, suggesting the involvement of opioid signaling molecules in tissue rejection; 3. In further experiments it was demonstrated that in mixed lymphocyte populations from different mice, the DNA synthesis inhibitor, mitomycin C, reduced the lymphocyte proliferative response as did naltrexone; 4. Mice injected with naltrexone for 10 days and given concanavalin A exhibited a suppressed spleen lymphocyte proliferative response compared to controls. Taken together, these data suggest that endogenous opioid signals not only activate immunocytes, but also stimulate DNA synthesis.
Insights
Transplanted cardiac tissue is rejected by the host within 9 days. Naltrexone, an opiate antagonist, extended survival to 13 days, indicating opioid signaling
Area of Science:
- Immunology
- Pharmacology
- Transplantation Biology
Background:
- Cardiac tissue transplantation triggers an inflammatory response leading to host rejection.
- Opioid signaling molecules are implicated in the complex mechanisms of immune response and tissue survival.
Purpose of the Study:
- To investigate the role of endogenous opioid signals in the immune response to cardiac allografts.
- To determine the effect of naltrexone on the survival of transplanted cardiac tissue.
- To explore the impact of naltrexone on lymphocyte proliferation and DNA synthesis.
Main Methods:
- Cardiac tissue transplantation in a murine model.
- Administration of naltrexone (opiate antagonist) and mitomycin C (DNA synthesis inhibitor).
- Assessment of tissue survival time and lymphocyte proliferative response using assays like concanavalin A stimulation.
Main Results:
- Cardiac allograft survival was significantly extended from 9 to 13 days with naltrexone treatment.
- Naltrexone and mitomycin C both reduced lymphocyte proliferative responses in mixed lymphocyte populations.
- Naltrexone administration suppressed spleen lymphocyte proliferation in concanavalin A-stimulated mice.
Conclusions:
- Endogenous opioid signals play a crucial role in activating immunocytes and stimulating DNA synthesis.
- Naltrexone demonstrates immunomodulatory effects, impacting both tissue rejection and lymphocyte activation.
- Targeting opioid signaling pathways may offer novel therapeutic strategies for enhancing transplant survival.